• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本近期关于全氟化合物(PFC)乳液作为氧载体的研究。

Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.

作者信息

Mitsuno T, Ohyanagi H, Yokoyama K, Suyama T

机构信息

Kasuga Memorial Hospital, Kobe, Japan.

出版信息

Biomater Artif Cells Artif Organs. 1988;16(1-3):365-73. doi: 10.3109/10731198809132587.

DOI:10.3109/10731198809132587
PMID:3052644
Abstract

In summary, we have discussed PFC emulsions as oxygen carriers, and concluded as follows: PFC emulsions which are clinically usable at present, such as Fluosol-DA, have some negative points. For instance, there is the requirement of relatively high FiO2 level, short retention time in the blood stream, slow excretion rate from the organs, limited dosage for infusion, and so on. However, in the clinical cases of moderate acute anemia, the consumed oxygen in the PFC phase was nearly 30% of that in the hemoglobin phase in the administration of only 1,000 ml of Fluosol-DA. It strongly suggests that PFC emulsion can carry a considerable amount of oxygen to the tissues and play an important role in improving the tissue hypoxia. Moreover, we surgeons wish to say that there is a great difference for the surgeons' mental state during a surgical operation between the cases where no blood transfusion is allowed for a religious or other reason, and the cases where we may use Fluosol-DA depending on the patients' condition. In the former cases, surgeons will be under stress such that he or she might cause the patients to lose blood excessively. On the other hand, when the surgeon has something in reserve, that is, when he or she may use Fluosol-DA if needed, a good result will usually be obtained in the operation, even without actually using Fluosol-DA. One might be led to say that a key point for the success of operations is the surgeon's mental condition, freedom from anxiety.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

总之,我们讨论了作为氧载体的全氟碳化合物(PFC)乳剂,并得出以下结论:目前临床上可用的PFC乳剂,如氟碳乳剂(Fluosol-DA),存在一些缺点。例如,需要相对较高的吸入氧分数(FiO2)水平,在血流中的保留时间短,从器官排出的速率慢,输注剂量有限等。然而,在中度急性贫血的临床病例中,仅给予1000ml氟碳乳剂时,PFC阶段消耗的氧气几乎是血红蛋白阶段的30%。这有力地表明,PFC乳剂可以向组织输送相当数量的氧气,并在改善组织缺氧方面发挥重要作用。此外,我们外科医生想说,在手术过程中,由于宗教或其他原因不允许输血的情况与根据患者情况可以使用氟碳乳剂的情况相比,外科医生的精神状态有很大差异。在前一种情况下,外科医生会承受压力,以至于可能导致患者失血过多。另一方面,当外科医生有所储备,即如果需要可以使用氟碳乳剂时,即使实际上没有使用氟碳乳剂,手术通常也会取得良好的效果。有人可能会说手术成功的关键在于外科医生的精神状态,即没有焦虑。(摘要截断于250字)

相似文献

1
Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan.日本近期关于全氟化合物(PFC)乳液作为氧载体的研究。
Biomater Artif Cells Artif Organs. 1988;16(1-3):365-73. doi: 10.3109/10731198809132587.
2
Present status of clinical studies of Fluosol-DA (20%) in Japan.氟碳乳剂(20%)在日本的临床研究现状。
Int Anesthesiol Clin. 1985 Spring;23(1):169-84. doi: 10.1097/00004311-198502310-00016.
3
Development of a perfluorochemical emulsion as a blood gas carrier.
Artif Organs. 1984 Feb;8(1):25-33. doi: 10.1111/j.1525-1594.1984.tb04240.x.
4
U.S. clinical studies of the treatment of anemia with fluosol-DA 20%.使用20%全氟三丙胺乳剂治疗贫血的美国临床研究。
Artif Organs. 1984 Feb;8(1):19-24. doi: 10.1111/j.1525-1594.1984.tb04239.x.
5
Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).全氟化学血液代用品氟碳乳剂(20%)的血液动力学及氧运输效应
Crit Care Med. 1980 Dec;8(12):738-41. doi: 10.1097/00003246-198012000-00009.
6
Experimental studies on fluosol DA administration in acute pancreatitis.急性胰腺炎中氟碳代血液(Fluosol DA)给药的实验研究。
Biomater Artif Cells Artif Organs. 1988;16(1-3):585-94. doi: 10.3109/10731198809132613.
7
Development of a perfluorochemical whole blood substitute (Fluosol-DA, 20%)--an overview of clinical studies with 185 patients.
Prog Clin Biol Res. 1981;55:609-28.
8
Fluorocarbon emulsions: methodology to assess efficacy.
Crit Care Med. 1982 Mar;10(3):149-54. doi: 10.1097/00003246-198203000-00002.
9
Perfluorochemical emulsion oxygen transport fluids: a clinical review.全氟化合物乳剂氧输送液:临床综述
Annu Rev Med. 1985;36:309-13. doi: 10.1146/annurev.me.36.020185.001521.
10
Development and clinical application of perfluorochemical artificial blood.全氟化合物人造血液的研制与临床应用
Int J Artif Organs. 1986 Sep;9(5):363-8.

引用本文的文献

1
Administration of a second generation perfluorochemical in combination with hyperbaric oxygenation does not provide additional benefit in a model of permanent middle cerebral artery occlusion in rats.在大鼠永久性大脑中动脉闭塞模型中,第二代全氟化合物与高压氧联合使用并不能带来额外益处。
Springerplus. 2014 Jan 17;3:32. doi: 10.1186/2193-1801-3-32. eCollection 2014.
2
[Artificial oxygen carriers as an alternative to red blood cell transfusion].[人工氧载体作为红细胞输血的替代物]
Anaesthesist. 2005 Aug;54(8):741-54. doi: 10.1007/s00101-005-0893-3.